Literature DB >> 17189069

Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis.

Zafer Kocak1, Gerben R Borst, Jing Zeng, Sumin Zhou, Donna R Hollis, Junan Zhang, Elizabeth S Evans, Rodney J Folz, Terrence Wong, Daniel Kahn, Jose S A Belderbos, Joos V Lebesque, Lawrence B Marks.   

Abstract

PURPOSE: Clinical and 3D dosimetric parameters are associated with symptomatic radiation pneumonitis rates in retrospective studies. Such parameters include: mean lung dose (MLD), radiation (RT) dose to perfused lung (via SPECT), and pre-RT lung function. Based on prior publications, we defined pre-RT criteria hypothesized to be predictive for later development of pneumonitis. We herein prospectively test the predictive abilities of these dosimetric/functional parameters on 2 cohorts of patients from Duke and The Netherlands Cancer Institute (NKI). METHODS AND MATERIALS: For the Duke cohort, 55 eligible patients treated between 1999 and 2005 on a prospective IRB-approved study to monitor RT-induced lung injury were analyzed. A similar group of patients treated at the NKI between 1996 and 2002 were identified. Patients believed to be at high and low risk for pneumonitis were defined based on: (1) MLD; (2) OpRP (sum of predicted perfusion reduction based on regional dose-response curve); and (3) pre-RT DLCO. All doses reflected tissue density heterogeneity. The rates of grade > or =2 pneumonitis in the "presumed" high and low risk groups were compared using Fisher's exact test.
RESULTS: In the Duke group, pneumonitis rates in patients prospectively deemed to be at "high" vs. "low" risk are 7 of 20 and 9 of 35, respectively; p = 0.33 one-tailed Fisher's. Similarly, comparable rates for the NKI group are 4 of 21 and 6 of 44, respectively, p = 0.41 one-tailed Fisher's.
CONCLUSION: The prospective model appears unable to accurately segregate patients into high vs. low risk groups. However, considered retrospectively, these data are consistent with prior studies suggesting that dosimetric (e.g., MLD) and functional (e.g., PFTs or SPECT) parameters are predictive for RT-induced pneumonitis. Additional work is needed to better identify, and prospectively assess, predictors of RT-induced lung injury.

Entities:  

Mesh:

Year:  2007        PMID: 17189069      PMCID: PMC1829491          DOI: 10.1016/j.ijrobp.2006.09.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  29 in total

1.  Quantification of radiation-induced regional lung injury with perfusion imaging.

Authors:  L B Marks; M T Munley; D P Spencer; G W Sherouse; G C Bentel; J Hoppenworth; M Chew; R J Jaszczak; R E Coleman; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-05-01       Impact factor: 7.038

2.  Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer.

Authors:  Katrien De Jaeger; Yvette Seppenwoolde; Liesbeth J Boersma; Sara H Muller; Paul Baas; José S A Belderbos; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-04-01       Impact factor: 7.038

3.  Challenges in defining radiation pneumonitis in patients with lung cancer.

Authors:  Zafer Kocak; Elizabeth S Evans; Su-Min Zhou; Keith L Miller; Rodney J Folz; Timothy D Shafman; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

4.  Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.

Authors:  Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig; Louise Braban; Steven A Leibel; C Clifton Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-04       Impact factor: 7.038

5.  Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?

Authors:  M Fan; L B Marks; D Hollis; G G Bentel; M S Anscher; G Sibley; R E Coleman; R J Jaszczak; M T Munley
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

Review 6.  Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems.

Authors:  S McDonald; P Rubin; T L Phillips; L B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

7.  First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy.

Authors:  José S A Belderbos; Katrien De Jaeger; Wilma D Heemsbergen; Yvette Seppenwoolde; Paul Baas; Liesbeth J Boersma; Joos V Lebesque
Journal:  Radiother Oncol       Date:  2003-02       Impact factor: 6.280

8.  The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram.

Authors:  L B Marks; D P Spencer; G W Sherouse; G Bentel; R Clough; K Vann; R Jaszczak; R E Coleman; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-08-30       Impact factor: 7.038

9.  Risk factors of pneumonitis following chemoradiotherapy for lung cancer.

Authors:  M Yamada; S Kudoh; K Hirata; T Nakajima; J Yoshikawa
Journal:  Eur J Cancer       Date:  1998-01       Impact factor: 9.162

10.  Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.

Authors:  Yvette Seppenwoolde; Katrien De Jaeger; Liesbeth J Boersma; José S A Belderbos; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-01       Impact factor: 7.038

View more
  22 in total

1.  Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy.

Authors:  An-Na Tong; Peng Yan; Guang-Hui Yuan; Xiao-Yan Lv; Hai Gong; Hui Zhao; Yan-Ming Wang
Journal:  Mol Clin Oncol       Date:  2014-12-10

2.  Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy.

Authors:  Dongqing Wang; Baosheng Li; Zhongtang Wang; Jian Zhu; Hongfu Sun; Jian Zhang; Yong Yin
Journal:  Exp Ther Med       Date:  2011-06-29       Impact factor: 2.447

3.  Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.

Authors:  Richard Castillo; Ngoc Pham; Edward Castillo; Samantha Aso-Gonzalez; Sobiya Ansari; Brian Hobbs; Diana Palacio; Heath Skinner; Thomas M Guerrero
Journal:  Radiology       Date:  2015-01-13       Impact factor: 11.105

Review 4.  A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain.

Authors:  Mohamad B Dabjan; Carolyn Ms Buck; Isabel L Jackson; Zeljko Vujaskovic; Brian Marples; Julian D Down
Journal:  Lab Invest       Date:  2016-08-01       Impact factor: 5.662

5.  Elevation in exhaled nitric oxide predicts for radiation pneumonitis.

Authors:  Thomas Guerrero; Josue Martinez; Matthew R McCurdy; Michael Wolski; Mary Francis McAleer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-04       Impact factor: 7.038

6.  Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.

Authors:  Jose Luis Lopez Guerra; Daniel Gomez; Yan Zhuang; Lawrence B Levy; George Eapen; Hongmei Liu; Radhe Mohan; Ritsuko Komaki; James D Cox; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-01       Impact factor: 7.038

7.  Combining multiple models to generate consensus: application to radiation-induced pneumonitis prediction.

Authors:  Shiva K Das; Shifeng Chen; Joseph O Deasy; Sumin Zhou; Fang-Fang Yin; Lawrence B Marks
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

Review 8.  PET in the management of locally advanced and metastatic NSCLC.

Authors:  Willem Grootjans; Lioe-Fee de Geus-Oei; Esther G C Troost; Eric P Visser; Wim J G Oyen; Johan Bussink
Journal:  Nat Rev Clin Oncol       Date:  2015-04-28       Impact factor: 66.675

9.  On the use of hyperpolarized helium MRI for conformal avoidance lung radiotherapy.

Authors:  C W Hodge; Wolfgang A Tomé; S B Fain; S M Bentzen; M P Mehta
Journal:  Med Dosim       Date:  2009-10-30       Impact factor: 1.482

10.  Radiation pneumonitis: correlation of toxicity with pulmonary metabolic radiation response.

Authors:  Justin P Hart; Matthew R McCurdy; Muthuveni Ezhil; Wei Wei; Meena Khan; Dershan Luo; Reginald F Munden; Valen E Johnson; Thomas M Guerrero
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-19       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.